The immunomodulating effects of moxifloxacin seem to be effective in downregulating inflammatory reactions. This presumed effect was tested in endotoxin (ETX)-induced acute lung injury (ALI) in rats. After moxifloxacin treatment (10 mg/kg) of ETX-given rats, lung myeloperoxidase (MPO) activity, bronchoalveolar-lavage (BAL) protein, and the number of neutrophils in the BAL cells were measured. Light and electron microscopic structures were also examined. Electron microscopic CeCl3 histochemistry for the detection of hydrogen peroxide in the lungs and immunohistochemistry of cytosolic phospholipase A2 (cPLA2) in the lung tissues and BAL cells were performed. To examine the expression of TNFα in the lungs, western blotting was carried out with the lung tissues. ETX had accumulated neutrophils in the lungs, which was followed by lung leak. Oxidative stress occurred, and increased expression of cPLA2 in the lung tissues and BAL cells was observed in the ETX-given rats. Simultaneously, the expression of TNFα was enhanced by ETX. Moxifloxacin, however, decreased all these parameters, indicating that ALI may have been ameliorated. Moxifloxacin appears to ameliorate ETX-induced ALI partially through the suppression of cPLA2 in the lungs of rats.
Introduction
The pathophysiology of sepsis-induced acute lung injury (ALI) is characterized by the elevation of the inflammatory lipid mediators, free radicals from phagocytes causing oxidative stress and disruption of the endothelial and epithelial barrier in the lungs [16] .
Of these causative factors, to elicit acute inflammatory pulmonary edema, proinflammatory cytokines and products of activated phospholipase A2 (PLA2) play critical roles in septic ALI [21] . In patients with septic ALI, the levels of proinflammatory cytokines and lipid mediators are elevated [24] .
The increased levels of cytokines are followed by the activation of PLA2s, which releases several proinflammatory lipid mediators [1] . The chemokines and lipid molecules collectively lead to the chemotaxis of neutrophils into the lungs, and the accumulated neutrophils provoke oxidative stress and proteolytic inflammatory tissue injury [27] . The accumulation of neutrophils in the lungs is initiated by chemokines such as cytokine-induced neutrophil chemoattractant (CINC), but more importantly, as an effector of proinflammatory cytokines, PLA2s regulate the rate of inflammation by releasing proinflammatory lipid mediators [12] .
The pathophysiology of sepsis-induced ALI, however, is not that simple. Endotoxin (ETX) itself induces the immune system to process monocytes and macrophages to secrete various cytokines, and to activate transcriptional factor NFkB to initiate heterogeneous inflammatory reactions such as activation of adhesion molecules, coagulation process, and release of proteolytic enzymes from the neutrophils [18] .
The activation of PLA2s is only one of the processes for eliciting an inflammatory reaction in the lungs during ALI.
Recent studies on PLA2s, however, revealed new concepts on the roles of PLA2 associated with inflammation because successively novel PLA2s have been found, and these newly found PLA2s (including subtypes of cPLA2s) are presumed to have certain roles in the pathogenesis of inflammatory reaction [10] .
As one of the PLA2s that seem to be responsible for the inflammation in septic ALI, cytosolic PLA2 (cPLA2) is known to be involved in the neutrophilic oxidative stress and inflammation in the lungs [13] .
As the migration and release of proteolytic enzymes of neutrophils are regulated by the cPLA2-derived lipids, their suppression or inhibition could be beneficial in terms of diminishing lung tissue injury. Unfortunately, however, the trials that have been conducted to develop a new modality for treating ALI with the suppression of PLA2s have failed.
Moxifloxacin was recently elucidated to have immunoregulating effects, including suppression of neutrophilic migration and generation of proinflammatory cytokine from monocytes [3] . The anti-inflammatory effects of moxifloxacine, especially on LPS-induced ALI, were suggested in certain literature [8] .
In conjunction with the anti-inflammatory effects of moxifloxacin and the role of PLA2 in ALI, the possibility of the ameliorating property of moxifloxacin on ETX-induced ALI was probed in association with cPLA2 activation and neutrophilic oxidative stress.
Materials and Methods
Reagents and experimental animals 
Experimental groups
Rats were allotted to three experimental groups 1) Sham group; rats were given 1.0 ml of normal saline intratracheally.
2) ETX group; rats were given 100 μg of ETX in 1.0 ml of normal saline intratracheally.
3) ETX+MO group; rats were given 100 μg of ETX in 1.0 ml of normal saline intratracheally and immediately after the instillation of ETX, moxifloxacin hydrochloride (MO, 10 mg/kg) was given intraperitoneally.
Induction of ALI
Rats were anesthetized with enflurane and xylazine and trachea was exposed. Eighteen gauge angiocatheter was inserted into the trachea and 100 μg of ETX in 1.0 ml of saline was insufflated. Five hours later, the rats were sacrificed for experiments.
Lung preparations for morphological examination 
Measurement of BAL protein and enumeration of BAL neutrophils:
Lungs were lavaged by cannulating the trachea and instilling 8.0 ml of saline into the lungs, withdrawing and reinstilling 3 times and then extracting as much fluid as possible. Collected lavage was centrifuged at 1,000× g for 10 min. The cellular pellet was resuspended with 1.0 ml of distilled water and 1.0 ml of Hank's balanced salt solution for a few seconds and centrifuged again. After supernatant was collected for protein measurement, the pellet was resuspended in 0.5 ml of normal saline. With 100 μl of resuspended solution, cytospin was performed for a differential count, and the cells were Wright stained . White blood cells were counted with hemocytometer, and the fraction of neutrophils was calculated by percentage of neutrophils in the differential count. With the collected supernatant, BAL protein was measured as previously described by Brown et al [23] .
Measurement of lung MPO activity
Lung myeloperoxidase (MPO) activity was measured as previously described by Goldblum et al [5] . Briefly, the frozen left lung at -70℃ was thawed and then homogenized 
Results
In the sham-treated rats, the lungs showed patent alveoli devoid of phagocytes (Fig. 1a) . By contrast, the lungs of the rats in the ETX group showed massive perivascular cuffing, and migration of neutrophils was noted (Fig. 1b, c, d , e, f).
The perivascular cuffing was very wide (Fig. 1b, bidirectional arrow), and disruption of the endothelial barrier was noted (Fig. 1b, arrow) . In the perivascular cuff, neutrophils were seen migrating into the alveoli (Fig. 1c) . In Fig. 1d , at the disrupted endothelial barrier, neutrophils were seen moving towards the alveoli (arrows). The extended vascular cuffing was so wide that the normal architecture of the alveoli was destroyed and alveolar flooding was observed. Neutrophils were visible in the perivascular cuff (Fig. 1e) . In Fig. 1f , numerous neutrophils and hyaline membranes were visible in the alveoli (arrow).
The site of the disrupted alveolar septa where neutrophils were accumulated was noted (arrow). In Fig. 1g and h, the effects of moxifloxacin were disclosed. In the patent alveoli, neutrophils were difficult to find, but interestingly, monocytes were clumped in the alveoli (Fig. 1g, arrows) . On the whole, the alveoli were patent, and infiltration or migration of neutrophils into the alveoli was not observed (Fig. 1h) .
ETX tremendously increased the accumulation of neutrophils in the lungs compared with the sham group.
The lung MPO activity (U/g of the lungs) of the ETX group was higher than that of the sham group (p<0.001).
Moxifloxacin decreased the lung MPO activity compared with ETX (p<0.05). Likewise, the number of BAL neutrophils showed similar results. The number of neutrophils was higher in the ETX group than in the sham group (p<0.001).
The number of BAL neutrophils in the ETX group was reduced by moxifloxacin (p<0.05) ( Table 1) .
As an index of lung injury, the protein content in BAL Phagocytes were not observed in the lungs (H&E staining, original mag ×100). Fig. 1b and Fig. 1c : By contrast, in the ETX group, wide perivascular cuffing (Fig. 1b, bidirectional arrow, H&E staining, original mag ×40) and disruptions of the endothelial lining were visible (Fig. 1b, arrow) . Through the endothelial disruptions, neutrophils were found migrating into the alveoli, and at the vicinity of the perivascular cuffing red blood cells and phagocytes were accumulated (Fig. 1c, H&E stain, original mag ×400) and hyaline membranes were visible (Fig. 1b, short arrow, H&E staining, original mag ×40). Fig.   1d and Fig. 1e : Through the disrupted endothelial barrier, phagocytes were found moving into the alveoli, and alveolar flooding was found to sweep over the alveoli (Fig. 1d, arrows, H&E stain, original mag ×40 ). In the alveolar flood, phagocytes were seen floating into the alveoli (Fig. 1e , arrows, H&E staining, original mag ×200). Fig. 1f : Infiltrated neutrophils in the alveoli and hyaline membranes were observed (arrows). Some alveoli were filled with phagocytes and proteinaceous fluid, which led to atelectasis of the lungs (H&E staining, original mag ×200). Fig. 1g : The effects of moxifloxacin reveal the migration and filling of alveoli with monocytes (arrows, H&E staining, original mag ×200). Fig. 1h : In the perivascular area, extravasations and dense cuffing of monocytes was observed, but the alveoli were relatively patent, and alveolar flooding was not visible. Generally, alveoli are patent, and neutrophilic migrations and hyaline membranes were difficult to find (H&E staining, original mag ×40).
(mg/two lungs) is presented in Table 2 . In the ETX group, the protein content was higher than that of the sham group (p<0.001). By contrast, moxifloxacin decreased (p<0.05) the protein content in the BAL of the ETX group.
Normal lamellar bodies were observed in the cytoplasm of the alveolar type II (AT II) cells. By contrast, enlarged, vacuolated lamellar bodies were observed in the cytoplasms (Fig. 2 ).
In the sham group, cerrous perhydroxide granules were not found around the AT II cells. By contrast, dense deposits of cerrous perhydroxide were found along the membranes of the AT II cells in the ETX group. Moxifloxacin, however, conspicuously reduced the deposits of cerrous perhydroxide granules in the ETX-given rats (Fig. 3) .
With DAB staining, the expression of cPLA2 was examined. In the sham group, the lungs showed patent alveoli, and few cells with activated cPLA2 were found (Fig.   4a ). By contrast, in the ETX group, numerous neutrophils whose cytoplasm was deeply stained with DAB were congested in the vascular lumen (arrow), and some were in the process of diapedesis (Fig. 4b) . Again, in the ETX group, the intima of the pulmonary capillary was deeply stained with DAB, which signifies the presence of cPLA2 activated by ETX. Several neutrophils with activated cPLA2s
were found (Fig. 4c) . Fig. 4d , e, and f show the effect of moxifloxacin on the activation of cPLA2 in the lungs of the rats in the ETX group. On the whole, the alveoli were patent, and specific pathological findings were not observed. A couple of monocytes were noted (arrow) (Fig. 4d) . Although massive extravasation of phagocytes occurred, monocytes were mainly visible, and few DAB-stained cells were found (Fig. 4c) . In addition, even though extravasated phagocytes were congested in the interstitium and perivascular space, few DAB-stained cells were found (arrows, Fig. 4f) . Almost all the BAL cells from the sham group were monocytes, which did not show stained cPLA2s. By contrast, the BAL cells from the ETX group showed bright, fluorescent neutrophils with activated cPLA2s. These activated-cPLA2-containing neutrophils disappeared almost completely, however, due to moxifloxacin (Fig. 5) . The expression of TNFα was upregulated by ETX, but moxifloxacin suppressed the upregulated expression of TNF α by ETX (Fig. 6 ). through the neutrophil-, cytokine-, and oxidant-mediated processes [4] . In all these inflammation processes, PLA2s are involved [19] . Although PLA2s have long been known as the regulators of the inflammatory process in ALI, the development of a therapeutic modality with the inhibition of PLA2 has been unsuccessful. The present data demonstrated that ETX-induced lung injury is preceded by neutrophilic infiltration, which is a prerequisite for neutrophilic tissue injury. Although the mechanism is still obscure, moxifloxacin drastically ameliorated these inflammatory changes with the diminution of pulmonary edema and the migration of neutrophils into the alveoli. Instead of the migration of neutrophils into the alveoli, monocytes filled the alveoli, and in the examination of the BAL cells, monocytes and neutropils were found intermingled.
Even though the role of neutrophilic oxidative stress is partial and limited, in the initial stage of ETX-induced ALI, it has a pivotal role of causing endothelial and epithelial injury through the disruption of the pulmonary surfactant [11] . The activation of PLA2s by ETX or by the cytokines secreted from phagocytes leads to the hydrolysis of the phospholipids of the surfactant, through which process toxic mediators are produced [6, 7] . The resultant phenomenon is the peculiar changes in the AT II cells, such as hypersecretion of the pulmonary surfactant and enlargement and vacuolization of the lamellar bodies in the cytoplasms of the AT II cells in the lungs [9] . According to Martensson [15] , these peculiar changes in the AT II cells are derived from oxidative stress, especially endogenous oxidative stress by the free radicals from neutrophils. In the present study, the AT II cells were characterized by the traits of endogenous oxidative stress, such as enlargement and vacuolization of the lamellar bodies and surfactant denaturation.
Under the effects of ETX, moxifloxacin suppressed or ameliorated the oxidative-stress-induced AT II cell morphology. The decreased production of hydrogen peroxide by moxifloxacin reflected the diminished endogenous oxidative stress. The amount of cerrous perhydroxide was reduced by moxifloxacin in the ETX group. These morphological and histochemical evidences show the effectiveness of moxifloxacin in alleviating acute inflammatory injury caused by ETX.
As mentioned earlier, ETX-induced ALI was closely linked to the activation of a PLA2 and cytokine network; therefore, the decreased activity of PLA2s might have been one of the causes of the diminished inflammatory changes in the lungs in this study. Of the many types of PLA2s, cPLA2s have been recognized as initiating the inflammatory process of ALI [20] . The roles of cPLA2s in ALI are diverse.
The end products of activated cPLA2s provoke free-radical release from the neutrophils by activating NADPH oxidase to change the hemodynamics and to upregulate the adhesion molecules for the phagocytes, and have direct cytotoxic effects on the endothelial and epithelial cells [14] .
In the present study, phagocytes were not found in the alveoli of the sham group, but in the ETX group, activated-cPLA2-containing neutrophils were congested in the capillaries. The activated-cPLA2-containing neutrophils migrated through the disrupted endothelial barrier into the alveoli. Even the endothelial cells showed increased expression of cPLA2. Moxifloxacin almost completely abolished these neutrophils, whose cytoplasms contained activated cPLA2s in the alveoli. Through the effect of moxifloxacin, the alveoli were rid of neutrophils, and very small portions of the alveoli were filled with monocytes, in which the expression of cPLA2s was not found. These morphological findings are consistent with the report of Uriarte and associates [25] in which they insisted that moxifloxacin inhibited the migration of neutrophils into the endothelial cells by inhibiting the production of TNF. By inhibiting the production of cytokines such as IL-6, IL-8, and TNF from monocytes, moxifloxacin has been alleged to exhibit the anti-inflammatory effects of moxifloxacin [22] .
Another interesting result of the present study is that in the BAL cells, moxifloxacin also dramatically suppressed the cPLA2s in the phagocytes, especially in the neutrophils. In 
